0 0 0 0 0.00109047950807262 -0.000393784266803973 -0.000393784266803973 -0.000393784266803973
Sign Up Today X
Thanks for submitting the form.
Stockreport

Should Amgen's (AMGN) Exclusive DISCO Oncology Deal Require Action From Investors? [Yahoo! Finance]

Amgen Inc. (AMGN)  More Company Research Source: Yahoo! Finance
Last amgen inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
based on a cell-surface target identified by DISCO's proteomics and protein community mapping platform, with DISCO eligible for up to US$618 million in potential payments plus royalties. The deal gives Amgen access to a differentiated surfaceome-targeting engine that can inform bispecific antibody-drug conjugates and T-cell engagers, potentially broadening its oncology toolkit against hard-to-treat tumors like small cell lung cancer and microsatellite-stable colorectal cancer. We'll now examine how gaining exclusive access to DISCO's surfaceome-targeting platform could influence Amgen's existing investment narrative and long-term outlook. Uncover the next big thing with financially sound penny stocks that balance risk and reward To own Amgen today, you need to believe its broad portfolio and late-stage pipeline can offset pricing and biosimilar pressures while funding heavy R&D and manufacturing spend. The DISCO license adds an early-stage oncology option, but it does not mate [Read more]
IMPACT SNAPSHOT EVENT TIME: AMGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
AMGN alerts
from News Quantified
AMGN
NEWS
AMGN
Earnings
AMGN
Analyst Actions
AMGN
SEC Filings
Stockreport

Should Amgen's (AMGN) Exclusive DISCO Oncology Deal Require Action From Investors? [Yahoo! Finance]

Amgen Inc.  (AMGN) 
More Company Research Source: Yahoo! Finance
Last amgen inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
based on a cell-surface target identified by DISCO's proteomics and protein community mapping platform, with DISCO eligible for up to US$618 million in potential payments plus royalties. The deal gives Amgen access to a differentiated surfaceome-targeting engine that can inform bispecific antibody-drug conjugates and T-cell engagers, potentially broadening its oncology toolkit against hard-to-treat tumors like small cell lung cancer and microsatellite-stable colorectal cancer. We'll now examine how gaining exclusive access to DISCO's surfaceome-targeting platform could influence Amgen's existing investment narrative and long-term outlook. Uncover the next big thing with financially sound penny stocks that balance risk and reward To own Amgen today, you need to believe its broad portfolio and late-stage pipeline can offset pricing and biosimilar pressures while funding heavy R&D and manufacturing spend. The DISCO license adds an early-stage oncology option, but it does not mate [Read more]
IMPACT SNAPSHOT
EVENT TIME:
AMGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS